No antioxidant effect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women

被引:20
作者
Bureau, I
Laporte, F
Favier, M
Faure, H
Fields, M
Favier, AE
Roussel, AM [1 ]
机构
[1] Univ Grenoble 1 Pharm, LBSO, F-38700 La Tronche, France
[2] Grenoble Hosp, Dept Gynecol, Grenoble, France
[3] USDA, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA
关键词
combined HRT; LDL oxidizability; oxidative stress biomarkers;
D O I
10.1080/07315724.2002.10719231
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: To compare oxidative stress and LDL oxidizability in postmenopausal women with and without HRT. Methods: In a cross sectional study, two groups of women, with or without combined per os HRT (1.5-2 mg estrogen associated with 10 mg dydrogesteron), were age and duration of menopause matched. Women were recruited after medical examination at LBSO (Oxidative Stress Laboratory), Joseph Fourier University, Grenoble, and Department of Gynecology, Grenoble University Hospital, France. Main outcome measures included determination of lipid profile and oxidative stress biomarkers (TBARS, LDL oxidizability, autoantibodies against oxidized-LDL). Measurement of circulating levels of vitamin C, E, beta-carotene, lycopene and total antioxidant plasma capacity. Results: HRT led to decreased plasma total and LDL cholesterol (p < 0.05), but did not affect oxidizability and oxidation of LDL. Circulating levels of antioxidant vitamins (beta-carotene, vitamin C, vitamin E/triglycerides) and total antioxidant capacity of plasma and lipid peroxidation, assessed by plasma TBARs, were not different from controls in postmenopausal women receiving HRT. Conclusion: This study suggests that even if combined HRT modifies the blood lipid profile, it does not appear to influence oxidative status.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 50 条
  • [2] ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS
    BERLINER, JA
    NAVAB, M
    FOGELMAN, AM
    FRANK, JS
    DEMER, LL
    EDWARDS, PA
    WATSON, AD
    LUSIS, AJ
    [J]. CIRCULATION, 1995, 91 (09) : 2488 - 2496
  • [3] DIFFERENCES IN LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND APOLIPOPROTEINS IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
    CAMPOS, H
    MCNAMARA, JR
    WILSON, PWF
    ORDOVAS, JM
    SCHAEFER, EJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) : 30 - 35
  • [4] CASTELLI WP, 1988, AM J OBSTET GYNECOL, V158, P1553, DOI 10.1016/0002-9378(88)90189-5
  • [5] CEBALLOSPICOT I, 1992, CLIN CHEM, V38, P66
  • [6] Antioxidant effect of short-term hormonal treatment in postmenopausal women
    Clemente, C
    Caruso, MG
    Berloco, P
    Notarnicola, M
    D'Attoma, B
    Osella, AR
    Guerra, V
    Buonsante, A
    Giannandrea, B
    Di Leo, A
    [J]. MATURITAS, 1999, 31 (02) : 137 - 142
  • [7] DUPIN H, 1992, APPORTS NUTRITIONNEL
  • [8] CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN
    ESTERBAUER, H
    STRIEGL, G
    PUHL, H
    ROTHENEDER, M
    [J]. FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01): : 67 - 75
  • [9] Favier A, 1997, ANN BIOL CLIN-PARIS, V55, P9
  • [10] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499